Wuhan Chinese Moxibustion Technology Dev. Co., Ltd.

FDA 483 - Wuhan Chinese Moxibustion Technology Dev. Co., Ltd.

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This 483 record concerns Wuhan Chinese Moxibustion Technology Dev. Co., Ltd., issued by the Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality), covering drugs.

Company: Wuhan Chinese Moxibustion Technology Dev. Co., Ltd.
Product Type: Drugs
Office: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)
Person: Alice S. Tsao (Consumer Safety Officer at FDA)

Open in Dashboard

ID · 163d380b-b929-44a2-8caf-f12e06618016